-
Something wrong with this record ?
Biological activities of undescribed North American lichen species
EA. Yeash, L. Letwin, L. Malek, Z. Suntres, K. Knudsen, LP. Christopher,
Language English Country Great Britain
Document type Journal Article
PubMed
28369962
DOI
10.1002/jsfa.8340
Knihovny.cz E-resources
- MeSH
- Anti-Bacterial Agents analysis pharmacology MeSH
- Antioxidants analysis pharmacology MeSH
- Gram-Negative Bacteria drug effects MeSH
- Gram-Positive Bacteria drug effects MeSH
- Humans MeSH
- Lichens chemistry metabolism MeSH
- MCF-7 Cells MeSH
- Cell Proliferation drug effects MeSH
- Antineoplastic Agents analysis pharmacology MeSH
- Plant Extracts pharmacology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- North America MeSH
BACKGROUND: Lichens provide a large array of compounds with the potential for pharmaceutical development. In the present study, extracts from three previously undescribed North American lichen species were examined for antioxidant, antibacterial and anticancer activities. RESULTS: The results from this study demonstrated the following: (i) Acarospora socialis ethanol extract exhibited significant DPPH antioxidant scavenging activities, which were concentration dependent; (ii) acetone and ethyl acetate extracts of Xanthoparmelia mexicana inhibited Gram-positive bacteria but had no effect on Gram-negative bacteria; X. mexicana acetone extract yielded a minimum inhibitory concentration (MIC) of 20.9 µg mL-1 against Staphylococcus aureus, and 41.9 µg mL-1 against Enterococcus faecalis; (iii) acetone extract of Lobothallia alphoplaca inhibited growth of cultured breast cancer MCF-7 cells with an effective concentration (EC50 ) of 87 µg mL-1 ; the MCF-7 cell cycle appears arrested in the G2 phase, whereas the DNA synthesis cell cycle (S) may be inhibited. CONCLUSION: New lichen species that possess strong biological activities have been identified. These lichens comprise secondary metabolites that possess antioxidant, antibacterial and anticancer properties. © 2017 Society of Chemical Industry.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016685
- 003
- CZ-PrNML
- 005
- 20180515103601.0
- 007
- ta
- 008
- 180515s2017 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/jsfa.8340 $2 doi
- 035 __
- $a (PubMed)28369962
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Yeash, Erik A $u South Dakota School of Mines and Technology, Rapid City, SD, USA.
- 245 10
- $a Biological activities of undescribed North American lichen species / $c EA. Yeash, L. Letwin, L. Malek, Z. Suntres, K. Knudsen, LP. Christopher,
- 520 9_
- $a BACKGROUND: Lichens provide a large array of compounds with the potential for pharmaceutical development. In the present study, extracts from three previously undescribed North American lichen species were examined for antioxidant, antibacterial and anticancer activities. RESULTS: The results from this study demonstrated the following: (i) Acarospora socialis ethanol extract exhibited significant DPPH antioxidant scavenging activities, which were concentration dependent; (ii) acetone and ethyl acetate extracts of Xanthoparmelia mexicana inhibited Gram-positive bacteria but had no effect on Gram-negative bacteria; X. mexicana acetone extract yielded a minimum inhibitory concentration (MIC) of 20.9 µg mL-1 against Staphylococcus aureus, and 41.9 µg mL-1 against Enterococcus faecalis; (iii) acetone extract of Lobothallia alphoplaca inhibited growth of cultured breast cancer MCF-7 cells with an effective concentration (EC50 ) of 87 µg mL-1 ; the MCF-7 cell cycle appears arrested in the G2 phase, whereas the DNA synthesis cell cycle (S) may be inhibited. CONCLUSION: New lichen species that possess strong biological activities have been identified. These lichens comprise secondary metabolites that possess antioxidant, antibacterial and anticancer properties. © 2017 Society of Chemical Industry.
- 650 _2
- $a antibakteriální látky $x analýza $x farmakologie $7 D000900
- 650 _2
- $a protinádorové látky $x analýza $x farmakologie $7 D000970
- 650 _2
- $a antioxidancia $x analýza $x farmakologie $7 D000975
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a gramnegativní bakterie $x účinky léků $7 D006090
- 650 _2
- $a grampozitivní bakterie $x účinky léků $7 D006094
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lišejníky $x chemie $x metabolismus $7 D008011
- 650 _2
- $a MFC-7 buňky $7 D061986
- 650 _2
- $a Severní Amerika $7 D009656
- 650 _2
- $a rostlinné extrakty $x farmakologie $7 D010936
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Letwin, Lyndon $u Department of Biology, Lakehead University, Thunder Bay, ON, Canada. Biorefining Research Institute, Lakehead University, Thunder Bay, ON, Canada.
- 700 1_
- $a Malek, Lada $u Department of Biology, Lakehead University, Thunder Bay, ON, Canada. Biorefining Research Institute, Lakehead University, Thunder Bay, ON, Canada.
- 700 1_
- $a Suntres, Zacharias $u Department of Biology, Lakehead University, Thunder Bay, ON, Canada. Biorefining Research Institute, Lakehead University, Thunder Bay, ON, Canada. Northern Ontario School of Medicine, Lakehead University, Thunder Bay, ON, Canada.
- 700 1_
- $a Knudsen, Kerry $u University of Life Sciences, Prague, Czech Republic.
- 700 1_
- $a Christopher, Lew P $u South Dakota School of Mines and Technology, Rapid City, SD, USA.
- 773 0_
- $w MED00003015 $t Journal of the science of food and agriculture $x 1097-0010 $g Roč. 97, č. 14 (2017), s. 4721-4726
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28369962 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180515103735 $b ABA008
- 999 __
- $a ok $b bmc $g 1300309 $s 1013525
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 97 $c 14 $d 4721-4726 $e 20170529 $i 1097-0010 $m Journal of the Science of Food and Agriculture $n J Sci Food Agric $x MED00003015
- LZP __
- $a Pubmed-20180515